banner image

News & Events

Stay up to date with latest activity at SHIL

SHIL to launch Phase 2 COVID-19 Innovation Fund

SHIL to launch Phase 2 COVID-19 Innovation Fund  image

A new phase 2 innovation fund from Scottish Health Innovations Ltd (SHIL) will launch on Wednesday 7 October. Designed to support NHS Scotland adapt, develop and strengthen in response to COVID-19, it will harness the knowledge and expertise of health and social care professionals across Scotland, encouraging them to come forward with innovative ideas.   

The package of support for NHS Scotland staff will include up to £25k of initial seed funding, combined with regulatory support, project management and the extensive innovation expertise of SHIL.

The process is designed to be simple, and whilst health and social care professionals are being targeted, students, volunteers, companies and others with innovative ideas that would benefit from collaboration with the NHS can also submit ideas.

Robert Rea, Head of Innovation at SHIL comments: “We received an overwhelming response to our first round of COVID-19 Innovation funding, and have some potentially transformative projects in the final stages of development. This new round of funding recognises the changes in NHS Scotland as a consequence of COVID-19. It is a very different environment - this is challenging but with this comes an opportunity to innovate, transform and use the crisis for positive change.”

Since 2002, SHIL has supported over 1800 innovative health ideas, successfully developed and commercialised a variety of products and technologies, helped form 6 new spin-out companies and successfully negotiated multiple commercial license deals with companies, both within the UK and internationally. A collaborative approach ensures projects are managed, in collaboration with the inventor and health board that would otherwise be difficult to balance with clinical or personal commitments.

The Innovation Call will launch on Wednesday 7 October. Stay up to date via @ScotHealthInno

More information

Back to News